Continuous glucose monitoring for intensive care patients
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests using a continuous glucose monitor to track blood sugar levels in intensive care patients. The monitor sends readings wirelessly, which may help doctors adjust insulin more quickly and safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You must have high blood sugar that needs insulin treatment while in the intensive care unit.
- You must have been in the intensive care unit for less than 48 hours.
- You must not have a serious allergy to tape or sticky adhesives.
- You cannot take part if your doctor expects you to be in the hospital for less than 24 hours or if you are not expected to survive.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This study compares two ways of checking blood sugar in the ICU: a continuous monitor (sensor under the skin) versus intermittent finger sticks. It aims to see which method is better for managing blood sugar levels in critically ill patients on insulin.
This study tests whether a small continuous glucose monitor (a sensor that checks your sugar levels all the time) can be used easily in youth who are in the hospital. It may help doctors track your blood sugar closely without needing as many finger sticks.
This trial tests a continuous glucose monitoring system for people in the intensive care unit (ICU). It checks how well the device measures blood sugar and if it can help predict outcomes for critically ill patients.
This trial tests a continuous glucose monitoring system (Syai Tag) in the intensive care unit (ICU). It aims to see how well it measures blood sugar levels safely compared to standard methods.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.